CD28 and neoplasm: To show how CReSCENT may be used for the analysis of scRNA-seq data, we performed an analysis of a publicly available human tumour-associated T cell scRNA-seq data set, containing data from the blood, lymph nodes, lungs and bone marrow from two donors, with or without CD3/CD28 T Cell Activator stimulation (12).